5 news items
CSL and Arcturus Therapeutics Announce Nature Communications Has Published Pivotal Data Demonstrating Efficacy And Tolerability Of COVID-19 Vaccine
ARCT
CSLLY
20 May 24
announce Nature Communications has published results from an integrated phase 1/2/3a/3b study evaluating the safety, immunogenicity, and efficacy
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
ARCT
CSLLY
20 May 24
Nature Communications has published results from an integrated phase 1/2/3a
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
ARCT
CSLLY
20 May 24
(NASDAQ:ARCT) today announce Nature Communications has published results from an integrated phase 1/2/3a
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
ARCT
AZN
BNTX
9 May 24
that direct the cells to make a protein using its natural machinery. When this synthetically developed mRNA reaches the cell in a protective bubble called
Earnings Scheduled For March 7, 2024
ABM
AEO
AFCG
7 Mar 24
(AMEX:SDPI) is likely to report earnings for its fourth quarter.
• Natural Resources
- Prev
- 1
- Next